Don Sapatkin's profile photo

Don Sapatkin

Philadelphia

Health Care Journalist at Freelance

Deputy health care editor @POLITICO @POLITICOPro. Love public health (@PhillyInquirer beat), backcountry canoe trips & Brooklyn. Sapatiwagon in my youth.

Featured in: Favicon managedhealthcareexecutive.com Favicon mindsitenews.org Favicon yahoo.com Favicon politico.com Favicon seattletimes.com Favicon startribune.com Favicon washingtontimes.com Favicon inquirer.com Favicon medicalxpress.com Favicon post-gazette.com

Articles

  • How Can Population Health Management Improve Chronic Kidney Disease Outcomes?

    1 week ago | managedhealthcareexecutive.com | Don Sapatkin

    Gaps between medical guidelines for managing chronic kidney disease (CKD) and how it is managed in practice have persisted for a decade, from poor patient education and awareness to inadequate diagnostic evaluation and delayed nephrology referral by primary care physicians, who manage most patients, particularly in the early stages. The result is additional disease progression, hospitalizations and deaths.

  • The ‘Healthy Immigrant Effect’ Is Alive and Well in Kidney Disease, Study Finds

    3 weeks ago | managedhealthcareexecutive.com | Don Sapatkin

    . Immigrants generally have worse social determinants of health, like income and education, than nonimmigrants. On the other hand, they benefit from the “healthy immigrant effect,” which has been linked to healthier lifestyle behaviors such as increased physical activity, diets containing more fruits and vegetables and less highly processed foods, lower smoking rates and consumption of alcohol. Which is more important for kidney health?

  • FDA Approves Novartis’ Oral Fabhalta as First Treatment for C3G.

    1 month ago | managedhealthcareexecutive.com | Don Sapatkin

    The FDA on Thursday approved Fabhalta (iptacopan) to treat complement 3 glomerulopathy (CG3), a progressive, ultrarare kidney disease with a poor prognosis for patients who previously could rely only on supportive care and often faced significant challenges. Fabhalta, marketed by the Swiss multinational Novartis AG, is the first and only treatment to reduce buildup of proteinuria (protein in the urine) as a result of inflammation caused by CG3.

  • Lurie Chicago Children’s Hospital Expands 24/7 In-House Dialysis Nursing Coverage

    1 month ago | managedhealthcareexecutive.com | Don Sapatkin

    Ann and Robert H. Lurie Chicago Children’s Hospital’s fully hospital-owned and -operated ADAPT program offering round-the-clock coverage was created in 2022, replacing an outsourced program, and recently expanded.

  • New Guidance for Managing People With Acute Kidney Injury Requiring Outpatient Dialysis

    1 month ago | managedhealthcareexecutive.com | Don Sapatkin

    Acute kidney injury (AKI), a serious and common complication experienced by hospitalized adults and children, requires in-hospital hemodialysis (AKI-D) in severe cases. Up to 30% of survivors must receive dialysis after discharge. Those patients remain at significantly increased risk of adverse outcomes, including chronic kidney disease, permanent dialysis dependence, cardiovascular disease, rehospitalization and death.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
1K
Tweets
1K
DMs Open
No
Don Sapatkin
Don Sapatkin @DonSapatkin
31 Jan 18

Great work on CDC's Brenda Fitzgerald by @politico's @Briannaehley and @SarahKarlin https://t.co/r7pJ05b8N5

Don Sapatkin
Don Sapatkin @DonSapatkin
22 Dec 17

Predictions on addiction range from pessimistic to apocalyptic @phillyhealthsci https://t.co/R4zWbQyPV1

Don Sapatkin
Don Sapatkin @DonSapatkin
14 Dec 17

RT @larry_levitt: The Senate tax bill repeals the individual mandate penalty starting in 2019, not 2018. If you're uninsured, you may want…